Decibel Therapeutics Inc (DBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,449 | -13,304 | -63,005 | -47,067 | -31,062 |
| Depreciation Amortization | 663 | 340 | 1,462 | 1,088 | 729 |
| Accounts receivable | N/A | -4,400 | 11,402 | 1,402 | 1,402 |
| Accounts payable and accrued liabilities | -267 | 394 | -3,128 | -981 | -2,097 |
| Other Working Capital | 856 | -5,210 | -618 | -7,551 | -8,166 |
| Other Operating Activity | 2,873 | 5,124 | -3,011 | 3,977 | 3,779 |
| Operating Cash Flow | $-27,324 | $-17,056 | $-56,898 | $-49,132 | $-35,415 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -254 | -266 | -463 | -266 | -221 |
| Purchase Of Investment | -13,157 | -2,917 | -97,513 | -71,858 | -39,250 |
| Sale Of Investment | 45,500 | 23,500 | 153,073 | 121,573 | 94,918 |
| Investing Cash Flow | $32,089 | $20,317 | $55,097 | $49,449 | $55,447 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 430 | 216 | N/A | 0 | N/A |
| Other Financing Activity | -27 | -19 | -213 | -158 | -104 |
| Financing Cash Flow | $403 | $197 | $-213 | $-158 | $-104 |
| Beginning Cash Position | 35,569 | 35,569 | 37,583 | 37,583 | 37,583 |
| End Cash Position | 40,737 | 39,027 | 35,569 | 37,742 | 57,511 |
| Net Cash Flow | $5,168 | $3,458 | $-2,014 | $159 | $19,928 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,324 | -17,056 | -56,898 | -49,132 | -35,415 |
| Capital Expenditure | -254 | -266 | -463 | -266 | -221 |
| Free Cash Flow | -27,578 | -17,322 | -57,361 | -49,398 | -35,636 |